Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

WP1066 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma — Stella

Home/Glioblastoma, IDH-Wildtype/WP1066 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma

View on ClinicalTrials.gov

Recruiting

Back to Glioblastoma, IDH-Wildtype trials

WP1066 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(2 sites)

United States

Northwestern University, Chicago, Illinois

Northwestern Medicine: Warrenville, Warrenville, Illinois

Key details

Phase

Safety & dosing

Sponsor

Northwestern University

Collaborators

Moleculin Biotech, Inc., National Cancer Institute (NCI)

Enrollment target

~39 participants

Started

May 2024

Primary completion

December 2027

Age range

18 Years and older

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.